Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nüßlein, Hubert G. (VerfasserIn) , Lorenz, Hanns-Martin (VerfasserIn)
Dokumenttyp: Article (Journal) Buch/Monographie
Sprache:Englisch
Veröffentlicht: London BioMed Central 2015
Online-Zugang:Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-194568
Volltext
Verfasserangaben:Hubert G. Nüßlein; Rieke Alten; Mauro Galeazzi; Hanns-Martin Lorenz; Michael T. Nurmohamed; William G. Bensen; Gerd R. Burmester; Hans-Hartmut Peter; Karel Pavelka; Melanie Chartier; Coralie Poncet; Christiane Rauch; Manuela Le Bars

MARC

LEADER 00000cam a2200000 c 4500
001 1653739940
003 DE-627
005 20230427140838.0
007 cr uuu---uuuuu
008 160208s2015 xx |||||o 00| ||eng c
024 7 |a urn:nbn:de:bsz:16-heidok-194568  |2 urn 
035 |a (DE-627)1653739940 
035 |a (DE-576)455164517 
035 |a (DE-599)BSZ455164517 
035 |a (OCoLC)928232663 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
082 0 |a 610 
082 0 4 |a 610 
084 |a 33  |2 sdnb 
084 |a 33  |2 sdnb 
100 1 |a Nüßlein, Hubert G.  |e VerfasserIn  |0 (DE-588)1096211130  |0 (DE-627)856608270  |0 (DE-576)467921121  |4 aut 
245 1 0 |a Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study  |c Hubert G. Nüßlein; Rieke Alten; Mauro Galeazzi; Hanns-Martin Lorenz; Michael T. Nurmohamed; William G. Bensen; Gerd R. Burmester; Hans-Hartmut Peter; Karel Pavelka; Melanie Chartier; Coralie Poncet; Christiane Rauch; Manuela Le Bars 
264 1 |a London  |b BioMed Central  |c 2015 
300 |a 1 Online-Ressource 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Aus: BMC Musculoskeletal Disorders, 16 (2015), Nr. 176. pp. 1-11. ISSN 1471-2474 
700 1 |a Lorenz, Hanns-Martin  |d 1962-  |e VerfasserIn  |0 (DE-588)112253865  |0 (DE-627)627277845  |0 (DE-576)167601369  |4 aut 
856 4 0 |u http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-194568  |q application/pdf  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a BO 
992 |a 20160208 
993 |a Article 
994 |a 2015 
998 |g 112253865  |a Lorenz, Hanns-Martin  |m 112253865:Lorenz, Hanns-Martin  |d 910000  |d 910100  |e 910000PL112253865  |e 910100PL112253865  |k 0/910000/  |k 1/910000/910100/  |p 4 
999 |a KXP-PPN1653739940  |e 3367855278 
BIB |a Y 
JSO |a {"language":["eng"],"id":{"eki":["1653739940"],"uri":["urn:nbn:de:bsz:16-heidok-194568"]},"type":{"bibl":"book","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2015","publisherPlace":"London","dateIssuedKey":"2015","publisher":"BioMed Central"}],"person":[{"given":"Hubert G.","display":"Nüßlein, Hubert G.","family":"Nüßlein","role":"aut"},{"role":"aut","family":"Lorenz","display":"Lorenz, Hanns-Martin","given":"Hanns-Martin"}],"physDesc":[{"extent":"1 Online-Ressource"}],"title":[{"title":"Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study","title_sort":"Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study"}],"note":["Aus: BMC Musculoskeletal Disorders, 16 (2015), Nr. 176. pp. 1-11. ISSN 1471-2474"],"recId":"1653739940","name":{"displayForm":["Hubert G. Nüßlein; Rieke Alten; Mauro Galeazzi; Hanns-Martin Lorenz; Michael T. Nurmohamed; William G. Bensen; Gerd R. Burmester; Hans-Hartmut Peter; Karel Pavelka; Melanie Chartier; Coralie Poncet; Christiane Rauch; Manuela Le Bars"]}} 
SRT |a NUESSLEINHPROGNOSTIC2015